文献速递血栓与止血

直接抗人球蛋白试验阳性与儿童慢性免疫性血小板减少症及二线治疗使用的关联:一项多机构回顾性分析

Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi-institutional review.
PubMed 文献 · Am J Hematol · 2019-02-04

该多机构回顾性研究纳入311例儿童免疫性血小板减少症(ITP)患者,在216例接受检测且疾病状态已知的患者中,直接抗人球蛋白试验(DAT)阳性与慢性ITP(29.2% vs 8.1%,P<0.001)及需二线药物治疗(38.5% vs 11.4%,P<0.001)相关;控制Evans综合征后,DAT阳性仍独立关联慢性ITP(OR=2.7,95%CI:1.0-7.2,P=0.041)和二线药物使用(OR=3.6,95%CI:1.7-7.7,P=0.001)。

要点

  • DAT阳性与儿童慢性ITP相关(29.2% vs 8.1%,P<0.001)。
  • DAT阳性与需二线药物治疗相关(38.5% vs 11.4%,P<0.001)。
  • 控制Evans综合征后,DAT阳性独立关联慢性ITP(OR=2.7)和二线治疗(OR=3.6)。

核心结论

  • 这些发现表明DAT阳性与慢性疾病以及需要二线药物的难治性疾病存在关联。

研究设计与样本

  • 多机构回顾性综述,纳入311例儿童ITP患者,旨在识别与疾病病程相关的临床特征。

主要发现

  • 在216例接受检测且疾病状态已知的患者中,DAT阳性与慢性ITP vs 自发缓解相关(29.2% vs 8.1%,P<0.001)。
  • 在241例患者中,DAT阳性与需二线药物治疗相关(38.5% vs 11.4%,P<0.001)。
  • 控制Evans综合征后,DAT阳性独立关联慢性ITP(OR=2.7,95%CI:1.0-7.2,P=0.041)。
  • 控制Evans综合征后,DAT阳性独立关联二线药物使用(OR=3.6,95%CI:1.7-7.7,P=0.001)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune thrombocytopenia (ITP) is the most common autoimmune cytopenia in children. Approximately, 25% of patients develop chronic disease, which may be unpredictable and challenging to treat. It is not currently possible to predict at the time of presentation which patients will have chronic disease or will experience symptoms requiring second-line therapy defined as treatment beyond corticosteroids, intravenous immunoglobulin, or Rh immune globulin. A multi-institutional retrospective review of 311 pediatric patients with ITP was performed with the goal of identifying clinical characteristics associated with disease course. In a cohort of 216 patients tested and for whom disease status was known, a positive direct antiglobulin test (DAT) was associated with chronic ITP vs spontaneous resolution of disease (29.2% vs 8.1%, P < 0.001) as well as the need for treatment with second line agents (38.5% vs 11.4%, P < 0.001) in 241 patients. Controlling for the effect of Evans syndrome, defined as having two immune cytopenias, a positive DAT was independently associated with chronic ITP (OR = 2.7, 95% CI: 1.0-7.2, P = 0.041) and use of second-line agents (OR: 3.6, 95% CI: 1.7-7.7, P = 0.001) by multivariate logistic regression model. These findings demonstrate an association with positive DAT and chronic disease, as well as refractory disease requiring second-line agents.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Kim TO, Grimes AB, Kirk S, et al. Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi-institutional review. Am J Hematol. 2019. PMID: 30663792. doi:10.1002/ajh.25409

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。